Retatrutide 10mg

Retatrutide is a next-generation triple receptor agonist simultaneously targeting GLP-1, GIP, and glucagon receptors — making it the first 'triagonist' of its class. Researched for its compounded metabolic effects including enhanced energy expenditure (via glucagon receptor activation), superior adipose tissue reduction, improved insulin sensitivity, and hepatic lipid modulation. Early research suggests metabolic outcomes that surpass dual agonists like tirzepatide. A cutting-edge compound for advanced metabolic research. Lyophilized powder. For research purposes only.

For Research Use Only · Not for Human Consumption · Not FDA Approved